$AIMD
Ainos, Inc. Stock $aimd

$aimd Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-K Financial Statement

#000143774920006575 Filed on March 30, 2020

Income Statement

Concept	2020 Q1	2019	2018 Q4
Revenue	$15.20K	$11.73K	$10.00K
YoY Change	272.91%	-84.91%
Cost Of Revenue	$10.81K	$8.772K	$0.00
YoY Change	297.57%	-86.48%
Gross Profit	$4.394K	$2.959K	$0.00
YoY Change	223.56%	-76.97%
Gross Profit Margin	28.91%	25.22%	0.0%
Selling, General & Admin	$380.3K	$1.531M	$450.0K
YoY Change	-2.36%	16.42%	150.0%
% of Gross Profit	8654.26%	51735.79%
Research & Development	$0.00	$52.51K	$30.00K
YoY Change	-100.0%	61.12%
% of Gross Profit	0.0%	1774.59%
Depreciation & Amortization		$10.58K
YoY Change		-40.88%
% of Gross Profit		357.52%
Operating Expenses	$380.3K	$1.583M	$490.0K
YoY Change	-2.96%	17.5%	172.22%
Operating Profit	-$375.9K	-$1.580M	-$490.0K
YoY Change	-3.75%	18.41%	172.22%
Interest Expense	-$1.005K	-$885.00	$0.00
YoY Change	-213.56%	-122.33%	-100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$380.0K	-$1.580M	-$490.0K
YoY Change	-2.56%	17.91%	133.33%
Income Tax
% Of Pretax Income
Net Earnings	-$376.9K	-$1.581M	-$500.0K
YoY Change	-3.71%	18.13%	138.1%
Net Earnings / Revenue	-2479.47%	-13479.65%	-5000.0%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.14	-$594.0K	-$0.20
COMMON SHARES
Basic Shares Outstanding	40.52M
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q1	2019	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$290.0K	$410.0K	$1.280M
YoY Change	-72.38%	-67.97%	-35.35%
Cash & Equivalents	$289.6K	$410.0K	$1.277M
Short-Term Investments
Other Short-Term Assets	$30.00K	$30.00K	$30.00K
YoY Change	50.0%	0.0%	-62.5%
Inventory	$4.071K	$0.00
Prepaid Expenses
Receivables	$12.58K
Other Receivables	$0.00
Total Short-Term Assets	$331.9K	$450.0K	$1.303M
YoY Change	-69.02%	-65.38%	-37.48%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.486K	$10.00K	$14.01K
YoY Change	-59.28%	0.0%	-48.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$147.6K	$150.0K	$160.5K
YoY Change	-4.49%	-6.25%	-23.36%
TOTAL ASSETS
Total Short-Term Assets	$331.9K	$450.0K	$1.303M
Total Long-Term Assets	$147.6K	$150.0K	$160.5K
Total Assets	$479.5K	$600.0K	$1.464M
YoY Change	-60.89%	-58.9%	-36.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$300.0K	$210.0K	$120.0K
YoY Change	114.29%	75.0%	-25.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$510.0K	$440.0K	$510.0K
YoY Change	6.25%	-13.73%	-42.7%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$912.9K	$750.0K	$733.6K
YoY Change	35.49%	2.74%	-59.76%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$912.9K	$750.0K	$733.6K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$912.9K	$750.0K	$733.6K
YoY Change	35.49%	2.74%	-59.76%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.147M		-$3.188M
YoY Change	43.77%		69.23%
Common Stock	$405.2K		$391.2K
YoY Change	2.4%		68.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$433.4K	-$160.0K	$730.1K
YoY Change
Total Liabilities & Shareholders Equity	$479.5K	$600.0K	$1.464M
YoY Change	-60.89%	-58.9%	-36.19%

Cashflow Statement

Concept	2020 Q1	2019	2018 Q4
OPERATING ACTIVITIES
Net Income	-$376.9K	-$1.581M	-$500.0K
YoY Change	-3.71%	18.13%	138.1%
Depreciation, Depletion And Amortization		$10.58K
YoY Change		-40.88%
Cash From Operating Activities	-$119.5K	-$909.5K	-$310.0K
YoY Change	-44.74%	-9.88%	-11.43%
INVESTING ACTIVITIES
Capital Expenditures		$1.638K	$0.00
YoY Change		-66.63%	-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$13.11K	-$70.00K
YoY Change		80.12%	600.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		54.97K	450.0K
YoY Change		-78.44%	-79.55%
NET CHANGE
Cash From Operating Activities	-119.5K	-909.5K	-310.0K
Cash From Investing Activities		-13.11K	-70.00K
Cash From Financing Activities		54.97K	450.0K
Net Change In Cash	-119.5K	-867.6K	70.00K
YoY Change	-48.13%	13.94%	-96.2%
FREE CASH FLOW
Cash From Operating Activities	-$119.5K	-$909.5K	-$310.0K
Capital Expenditures		$1.638K	$0.00
Free Cash Flow	-$119.5K	-$911.1K	-$310.0K
YoY Change	-45.15%	-10.16%	-13.89%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2019	amar	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0
CY2018	amar	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0
CY2019Q4	amar	Common Stock Shares Outstanding And Reserved CommonStockSharesOutstandingAndReserved	48673437
CY2019Q4	amar	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	5239000
CY2018Q4	amar	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	4992000
CY2019	amar	Dividends Payable Reversed DividendsPayableReversed
CY2018	amar	Dividends Payable Reversed DividendsPayableReversed	34280
CY2019	amar	Increase Decrease In Accrued Interest Related Party IncreaseDecreaseInAccruedInterestRelatedParty	2545
CY2018	amar	Increase Decrease In Accrued Interest Related Party IncreaseDecreaseInAccruedInterestRelatedParty	206
CY2019Q4	amar	Notes Payable Convertible Related Parties Classified Current NotesPayableConvertibleRelatedPartiesClassifiedCurrent	444581
CY2018Q4	amar	Notes Payable Convertible Related Parties Classified Current NotesPayableConvertibleRelatedPartiesClassifiedCurrent	513356
CY2019	amar	Proceeds From Convertible Notes Payable Related Party Debt ProceedsFromConvertibleNotesPayableRelatedPartyDebt
CY2018	amar	Proceeds From Convertible Notes Payable Related Party Debt ProceedsFromConvertibleNotesPayableRelatedPartyDebt
CY2019	amar	Proceeds Received For Stock Subscription ProceedsReceivedForStockSubscription
CY2018	amar	Proceeds Received For Stock Subscription ProceedsReceivedForStockSubscription
CY2019	amar	Repayments Of Convertible Notes Payable Related Party Debt RepaymentsOfConvertibleNotesPayableRelatedPartyDebt	70080
CY2018	amar	Repayments Of Convertible Notes Payable Related Party Debt RepaymentsOfConvertibleNotesPayableRelatedPartyDebt	195000
CY2018	amar	Reversal Of Dividends On Preferred Stock ReversalOfDividendsOnPreferredStock	34280
CY2019	amar	Reversal Of Dividends On Preferred Stock ReversalOfDividendsOnPreferredStock
CY2019	amar	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Discount Rate SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedDiscountRate	0.0296
CY2018	amar	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
CY2019	amar	Sharebased Compensation Arrangement By Sharebased Payment Award Options Granted Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
CY2018	amar	Stock Issued During Period Value Debt StockIssuedDuringPeriodValueDebt	178125
CY2019	amar	Stock Issued During Period Value Debt StockIssuedDuringPeriodValueDebt	100000
CY2018	amar	Stock Issued During Period Value Subscription StockIssuedDuringPeriodValueSubscription
CY2019	amar	Stock Issued During Period Value Subscription StockIssuedDuringPeriodValueSubscription
CY2019	amar	Stock Issued For Accrued Liabilities StockIssuedForAccruedLiabilities	69500
CY2018	amar	Stock Issued For Accrued Liabilities StockIssuedForAccruedLiabilities	116250
CY2019	amar	Stock Issued For Advances From Investors StockIssuedForAdvancesFromInvestors	100635
CY2018	amar	Stock Issued For Advances From Investors StockIssuedForAdvancesFromInvestors	721035
CY2019	amar	Stock Issued For Subscription StockIssuedForSubscription
CY2018	amar	Stock Issued For Subscription StockIssuedForSubscription	85791
CY2019	amar	Warrant Expense WarrantExpense	37984
CY2018	amar	Warrant Expense WarrantExpense	27765
CY2019	amar	Write Off Of Patent Costs WriteOffOfPatentCosts	0
CY2018	amar	Write Off Of Patent Costs WriteOffOfPatentCosts	16000
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001014763
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40516351
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019Q4	dei	Entity Public Float EntityPublicFloat	9138942
CY2019	dei	Entity Registrant Name EntityRegistrantName	AMARILLO BIOSCIENCES INC
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019	dei	Entity Small Business EntitySmallBusiness	true
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	208727
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	115313
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	102480
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	91901
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4207786
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3527238
CY2018	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	100366
CY2019	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	357053
CY2018	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	27765
CY2019	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	37984
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0
CY2018	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	7320
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11662
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	38296
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3099867
CY2019Q4	us-gaap	Assets Assets	596626
CY2018Q4	us-gaap	Assets Assets	1463700
CY2019Q4	us-gaap	Assets Current AssetsCurrent	445294
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2038150
CY2018Q4	us-gaap	Assets Current AssetsCurrent	1303234
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	409039
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1276654
CY2019	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-867615
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-761496
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40516351
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	39117524
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40516351
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	39117524
CY2019Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	2350949
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	405164
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	391175
CY2019	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Concentration of Credit Risk</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Financial instruments that potentially subject the Company to significant concentration of credit risk consist principally of cash. The Company has cash balances in a single U.S. financial institution which, from time to time, could exceed the federally insured limit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$250,000.</div> The Company maintains multiple accounts in its Taiwan Branch office which help to mitigate risk. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>cash held in Taiwan accounts amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$69,634.No</div> loss has been incurred related to the aforementioned concentration of cash.</div></div></div>
CY2019Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	444581
CY2018Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	513356
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	8772
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	64877
CY2019	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	100000
CY2018	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	178125
CY2018	us-gaap	Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued	116250
CY2019Q4	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	104250
CY2019Q4	us-gaap	Deferred Compensation Arrangement With Individual Shares Authorized For Issuance DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance	296520
CY2018	us-gaap	Deferred Compensation Arrangement With Individual Shares Issued DeferredCompensationArrangementWithIndividualSharesIssued	451480
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	5239000
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4992000
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5239000
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4992000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5239000
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4992000
CY2019	us-gaap	Depreciation Depreciation	10579
CY2018	us-gaap	Depreciation Depreciation	17895
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22241
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	56194
CY2019	us-gaap	Dividends Dividends	0
CY2019Q4	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	100000
CY2018Q4	us-gaap	Due To Affiliate Current DueToAffiliateCurrent	104952
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2019Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1308932
CY2019	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y273D
CY2019	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits
CY2018	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4131
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	92898
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	11957
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	10251
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	10251
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	10251
CY2019Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	10655
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	146263
CY2019Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	146263
CY2018Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	146456
CY2019	us-gaap	Gross Profit GrossProfit	2959
CY2018	us-gaap	Gross Profit GrossProfit	12847
CY2019	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	247000
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	251000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-332000
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-281000
CY2019	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	85000
CY2018	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	30000
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	261674
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	54844
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-22666
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5544
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-67400
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-885
CY2018	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-3963
CY2019	us-gaap	Interest Paid Net InterestPaidNet	903
CY2018	us-gaap	Interest Paid Net InterestPaidNet	3818
CY2019Q4	us-gaap	Inventory Net InventoryNet	4131
CY2018Q4	us-gaap	Inventory Net InventoryNet
CY2019Q4	us-gaap	Liabilities Liabilities	753308
CY2018Q4	us-gaap	Liabilities Liabilities	733621
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	596626
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1463700
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	753308
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	733621
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	54968
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	254979
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13107
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7277
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-909476
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1009198
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-1581298
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-1338639
CY2019	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3
CY2019	us-gaap	Open Tax Year OpenTaxYear	2019 2018 2017
CY2019	us-gaap	Operating Expenses OperatingExpenses	1583372
CY2018	us-gaap	Operating Expenses OperatingExpenses	1347523
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-1580413
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-1334676
CY2019Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	24948000
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	11469
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2369
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1638
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4908
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	32124
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	26580
CY2019	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	125048
CY2018	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	401250
CY2019	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt
CY2018	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	48729
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	107549
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	105911
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5069
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14010
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	52510
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	32591
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4769632
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3188334
CY2019	us-gaap	Revenues Revenues	11731
CY2018	us-gaap	Revenues Revenues	77724
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1530862
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1314932
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	2.76
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	288000
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4945000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4945000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4657000
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.38
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.038
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1217375
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.038
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.38
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.38
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y
CY2018Q3	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	539447
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2018	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	18852
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1122285
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	130000
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	116250
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	69500
CY2019	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	357053
CY2018	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	100366
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	470795
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	730079
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-156682
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-156682
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	730079
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div>
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39896388
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	35643804

Files In Submission

Name	View Source	Status
0001437749-20-006575-index-headers.html	Edgar Link	pending
0001437749-20-006575-index.html	Edgar Link	pending
0001437749-20-006575.txt	Edgar Link	pending
0001437749-20-006575-xbrl.zip	Edgar Link	pending
amar-20191231.xml	Edgar Link	completed
amar-20191231.xsd	Edgar Link	pending
amar-20191231_cal.xml	Edgar Link	unprocessable
amar-20191231_def.xml	Edgar Link	unprocessable
amar-20191231_lab.xml	Edgar Link	unprocessable
amar-20191231_pre.xml	Edgar Link	unprocessable
amar20191231_10k.htm	Edgar Link	pending
ex_179012.htm	Edgar Link	pending
ex_179013.htm	Edgar Link	pending
ex_179014.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AIMD
Ainos, Inc. Stock $aimd

2020 Q1 Form 10-K Financial Statement

#000143774920006575 Filed on March 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIMD Ainos, Inc. Stock $aimd

2020 Q1 Form 10-K Financial Statement

#000143774920006575 Filed on March 30, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIMD
Ainos, Inc. Stock $aimd